Efficacy and safety profile of vismodegib in a real‐world setting cohort of patients with advanced basal cell carcinoma in Argentina

Romina Cozzani; Roxana Aguila; Mariano Carrizo; Sergio Sanchez; Abel Gonzalez; A Chiacchietta; C Alonso; S Ferrandini; L Molinari; E Ruiz Murineddu; R Del Aguila; L Perelli; M Dupertuis; J Valentini; R Diaz Alfaro; L Mazzuoccolo; M Pelati; L Costa; S Rodriguez; D Ferrario; J Iturbe; R Mendez Roy; A Bozzano; A Romero; JC Paez; A Colombo Berra; G Streich; Aguilera Prisco; A Gonzalez; H Caceres; A Sosa; M Pascale; A Hunis; K Latorre; L Piazzoni; Lopez Di Noto; ME Oliva; M Melamed; L Arrozpide; L Daverede; N Ayala; V Martin Koller; D Vicente; Matias Maskin; A Abeldano; G Garbaos; G Palma;

doi:10.1111/ijd.14780

Efficacy and safety profile of vismodegib in a real‐world setting cohort of patients with advanced basal cell carcinoma in Argentina

International Journal of Dermatology ◽

10.1111/ijd.14780 ◽

2020 ◽

Vol 59 (5) ◽

pp. 627-632 ◽

Cited By ~ 2

Author(s):

Romina Cozzani ◽

Roxana Aguila ◽

Mariano Carrizo ◽

Sergio Sanchez ◽

Abel Gonzalez ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Real World ◽

Safety Profile ◽

Efficacy And Safety ◽

Real World Setting ◽

Advanced Basal Cell Carcinoma

Download Full-text

Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbidities

Dermatologic Therapy ◽

10.1111/dth.13108 ◽

2019 ◽

Vol 32 (6) ◽

Cited By ~ 4

Author(s):

Giulia Spallone ◽

Pietro Sollena ◽

Alessandra Ventura ◽

Maria C. Fargnoli ◽

Carlota Gutierrez ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950275.793505944 ◽

2015 ◽

Author(s):

John Carucci

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950275.793455534 ◽

2012 ◽

Author(s):

Alexander Eggermont

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

42-month follow-up of sonidegib efficacy and safety in advanced basal cell carcinoma: Final analysis from BOLT.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9551 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9551-9551 ◽

Cited By ~ 2

Author(s):

Michael Robert Migden ◽

Karl D. Lewis

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Final Analysis ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

A pivotal multicenter trial evaluating efficacy and safety of the hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with advanced basal cell carcinoma

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2011.11.630 ◽

2012 ◽

Vol 66 (4) ◽

pp. AB149

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Multicenter Trial ◽

Hedgehog Pathway ◽

Efficacy And Safety ◽

Hedgehog Pathway Inhibitor ◽

Advanced Basal Cell Carcinoma

Download Full-text

3332 Real-world treatment of vismodegib (VISMO)-related adverse events (AEs) in patients with locally advanced basal cell carcinoma: Report from the RegiSONIC Disease Registry Study

European Journal of Cancer ◽

10.1016/s0959-8049(16)31850-0 ◽

2015 ◽

Vol 51 ◽

pp. S675 ◽

Cited By ~ 2

Author(s):

M. Lacouture ◽

J. Guillen ◽

R. Kudchadkar ◽

G. Rogers ◽

T. Olencki ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Adverse Events ◽

Cell Carcinoma ◽

Basal Cell ◽

Real World ◽

Locally Advanced ◽

Registry Study ◽

Disease Registry ◽

Advanced Basal Cell Carcinoma

Download Full-text

3347 BOLT 18-month analysis: efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma (laBCC) and evaluation of tumor response using 2 sets of composite assessment criteria

European Journal of Cancer ◽

10.1016/s0959-8049(16)31865-2 ◽

2015 ◽

Vol 51 ◽

pp. S683-S684 ◽

Cited By ~ 1

Author(s):

R. Dummer ◽

V. Sondak ◽

J. Grichnik ◽

L. Schwartz ◽

A. Guminski ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Tumor Response ◽

Locally Advanced ◽

Assessment Criteria ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of vismodegib in advanced basal-cell carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950275.793456639 ◽

2012 ◽

Author(s):

Mark Faries

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text

Efficacy and Safety of the Hedgehog Pathway Inhibitor Vismodegib in Patients with Advanced Basal Cell Carcinoma (BCC): 12-Month Erivance BCC Study Update

Annals of Oncology ◽

10.1016/s0923-7534(20)33694-2 ◽

2012 ◽

Vol 23 ◽

pp. ix362 ◽

Cited By ~ 4

Author(s):

A. Sekulic ◽

M.R. Migden ◽

A. Oro ◽

K. Lewis ◽

J.D. Hainsworth ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Hedgehog Pathway ◽

Efficacy And Safety ◽

Hedgehog Pathway Inhibitor ◽

Advanced Basal Cell Carcinoma

Download Full-text

Efficacy and safety of sonidegib in patients with aggressive and nonaggressive subtypes of locally advanced basal cell carcinoma: Long-term 42-month results from the BOLT study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.06.736 ◽

2019 ◽

Vol 81 (4) ◽

pp. AB199

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Efficacy And Safety ◽

Advanced Basal Cell Carcinoma

Download Full-text